Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer (CRYO-PCA-IV)
A Prospective Multi-center Study to Compare the QOL and Efficacy of Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer.
Sponsor: Peking University First Hospital
This NA trial investigates Stage IV Prostate Cancer and is currently ongoing. Peking University First Hospital leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Jul 2017 [monthly]
Not Yet Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University First Hospital
- Shandong Cancer Hospital and Institute
- Shanghai Jiao Tong University School of Medicine
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- The Third Xiangya Hospital of Central South University
- Tianjin First Central Hospital
- Tianjin Medical University Cancer Institute and Hospital
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .